A number of medications have been approved by the U.S. Food and Drug Administration (FDA) for the treatment of attention-deficit/hyperactivity disorder (ADHD), and the evidence for the effectiveness of pharmacotherapy in ADHD is strong.
The most commonmedication-related problems inolder adultsinclude taking too high or too low of a dose, taking unnecessary medications, not taking medication as directed or at all, taking an ineffective medication, oradverse drug reactionssuch as confusion, bleeding and over-sedation. In addition, c...
Mental health therapy includes a variety of approaches such as talk therapy, cognitive behavioral therapy and couples counseling. Some people may find that therapy alone is helpful while others may find that medication alone is helpful. Many people, however, benefit from a combination of the two. ...
Onyda XR, First Liquid Nonstimulant for ADHD, Now Available in US Killian Meara;Lauren Biscaldi, MS, Managing Editor October 2nd 2024 The once-daily, extended release, oral suspension medication was approved by the FDA in May 2024.
From Medication To Meditation: Strategies For Managing ADHDSari R. Hornstein
European Guidelines on Managing Adverse Effects of Medication for ADHD. European Child and Adolescent Psychiatry. Eur Child Adolesc Psychiatry. 2011;20(1):17-37.Graham, J., Banaschewski, T., Buitelaar, J., Coghill, D., Danckaerts, M., Dittmann, R.W., ... Simonoff, E. (2011...
[30] specifically studied behavioral intervention to support sleep hygiene, educating individuals on management of light exposure and stimulant medication timing. Table 1. Prospective studies of sleep intervention in adults with ADHD. All of the studies reported favorable effects on sleep pattern, ...